Filing Details
- Accession Number:
- 0000884731-17-000002
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-01-10 18:17:46
- Reporting Period:
- 2017-01-09
- Filing Date:
- 2017-01-10
- Accepted Time:
- 2017-01-10 18:17:46
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 884731 | Ariad Pharmaceuticals Inc | ARIA | Biological Products, (No Disgnostic Substances) (2836) | 223106987 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1461612 | M Daniel Bollag | C/O Ariad Pharmaceuticals, Inc. 125 Binney Street Cambridge MA 02142 | Sr. Vp, Reg. Affairs & Quality | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-01-09 | 32,000 | $7.82 | 161,404 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-01-09 | 32,000 | $23.78 | 129,404 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2017-01-09 | 32,000 | $0.00 | 32,000 | $7.82 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2012-04-01 | 2021-04-01 | No | 4 | M | Direct |
Footnotes
- Shares were acquired from exercise of an outstanding stock option pursuant to a Rule 10b5-1 trading plan adopted on June 15, 2016
- Shares were sold pursuant to a Rule 10b5-1 trading plan dated June 15, 2016
Billionaire Hedge Funds
